AVITA Medical, a global regenerative medicine company, announces that the U.S. Food and Drug Administration (FDA) has approved the Company’s Premarket Approval (PMA) application to market the RECELL Autologous Cell Harvesting Device to treat severe thermal burns in patients 18 years and older.